Keryakos Hesham Kamal Habeeb, Mohammed Ahmed Ali, Higazi Aliaa Monir, Mahmoud Esraa Abdel Magid, Saad Zienab Mostafa
Department of Internal Medicine, Minia Faculty of Medicine, Minia University Hospital, El-Minia, Egypt.
Department of Internal Medicine, Minia Faculty of Medicine, Minia University Hospital, El-Minia, Egypt.
Curr Res Transl Med. 2020 Nov;68(4):237-243. doi: 10.1016/j.retram.2020.03.001. Epub 2020 Jul 1.
Spontaneous bacterial peritonitis (SBP) is a potentially lethal complication of ascites. The inflammatory response is very intense in case of SBP despite low concentration of bacteria in the ascitic fluid with IL-17A overproduced by intestinal Paneth cells and may have role in host immune defense and inflammatory response.
To study the diagnostic performance of serum and ascitic fluid IL-17A as a marker of SBP and its correlation with renal function.
120 cirrhotic patients including 80 patients with HCV-induced cirrhotic ascites but not with SBP and 40 patients with HCV-induced cirrhotic ascites with SBP were recruited. Serum and ascitic fluid IL17A were measured before and after treatment.
The mean serum and ascitic fluid levels of IL-17 in cirrhotic patients with SBP were significantly higher than in patients with cirrhosis without SBP (p < 0.001). Also, we found significant decline in both serum and ascitic fluid IL17 levels with successful treatment of SBP (p < 0.001). The sensitivity and specificity of serum IL17 was 100 % when using 92 pg/mL as cutoff. Meanwhile, sensitivity and specificity of ascitic fluid IL-17were 100 % when using 132 pg/mL as cutoff.
IL-17 could be used as a possible diagnostic biomarker for SBP especially in culture negative and non-neutrocytic SBP and in monitoring therapeutic response. Also, it was shown to be related to hepatic and renal functions deterioration.
自发性细菌性腹膜炎(SBP)是腹水的一种潜在致命并发症。尽管腹水细菌浓度较低,但SBP时炎症反应非常强烈,肠道潘氏细胞过度产生白细胞介素-17A(IL-17A),其可能在宿主免疫防御和炎症反应中起作用。
研究血清和腹水IL-17A作为SBP标志物的诊断性能及其与肾功能的相关性。
招募120例肝硬化患者,其中80例丙型肝炎病毒(HCV)诱导的肝硬化腹水患者但无SBP,40例HCV诱导的肝硬化腹水合并SBP患者。在治疗前后检测血清和腹水IL-17A。
SBP肝硬化患者的血清和腹水IL-17平均水平显著高于无SBP的肝硬化患者(p < 0.001)。此外,我们发现SBP成功治疗后血清和腹水IL-17水平均显著下降(p < 0.001)。以92 pg/mL为临界值时,血清IL-17的敏感性和特异性为100%。同时,以132 pg/mL为临界值时,腹水IL-17的敏感性和特异性为100%。
IL-17可作为SBP的一种可能的诊断生物标志物,尤其是在培养阴性和非中性粒细胞性SBP中,以及在监测治疗反应方面。此外,它还与肝肾功能恶化有关。